1. Home
  2. IHG vs NEUP Comparison

IHG vs NEUP Comparison

Compare IHG & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IHG
  • NEUP
  • Stock Information
  • Founded
  • IHG 1777
  • NEUP 1996
  • Country
  • IHG United Kingdom
  • NEUP United States
  • Employees
  • IHG N/A
  • NEUP N/A
  • Industry
  • IHG Hotels/Resorts
  • NEUP
  • Sector
  • IHG Consumer Discretionary
  • NEUP
  • Exchange
  • IHG Nasdaq
  • NEUP Nasdaq
  • Market Cap
  • IHG 19.9B
  • NEUP 17.4B
  • IPO Year
  • IHG N/A
  • NEUP N/A
  • Fundamental
  • Price
  • IHG $124.34
  • NEUP $4.88
  • Analyst Decision
  • IHG Hold
  • NEUP Strong Buy
  • Analyst Count
  • IHG 3
  • NEUP 1
  • Target Price
  • IHG N/A
  • NEUP $21.00
  • AVG Volume (30 Days)
  • IHG 197.8K
  • NEUP 1.6M
  • Earning Date
  • IHG 01-01-0001
  • NEUP 02-14-2025
  • Dividend Yield
  • IHG 1.26%
  • NEUP N/A
  • EPS Growth
  • IHG N/A
  • NEUP N/A
  • EPS
  • IHG 3.85
  • NEUP N/A
  • Revenue
  • IHG $4,923,000,000.00
  • NEUP $662,715.00
  • Revenue This Year
  • IHG N/A
  • NEUP N/A
  • Revenue Next Year
  • IHG $5.73
  • NEUP N/A
  • P/E Ratio
  • IHG $31.40
  • NEUP N/A
  • Revenue Growth
  • IHG 32.05
  • NEUP N/A
  • 52 Week Low
  • IHG $91.57
  • NEUP $2.12
  • 52 Week High
  • IHG $137.25
  • NEUP $15.72
  • Technical
  • Relative Strength Index (RSI)
  • IHG 31.91
  • NEUP N/A
  • Support Level
  • IHG $132.76
  • NEUP N/A
  • Resistance Level
  • IHG $136.79
  • NEUP N/A
  • Average True Range (ATR)
  • IHG 2.10
  • NEUP 0.00
  • MACD
  • IHG -1.38
  • NEUP 0.00
  • Stochastic Oscillator
  • IHG 2.53
  • NEUP 0.00

About IHG Intercontinental Hotels Group

InterContinental Hotels Group operates 946,000 rooms across 19 brands addressing the midscale through luxury segments, as of Dec. 31, 2023. Holiday Inn and Holiday Inn Express constitute the largest brand, while Hotel Indigo, Even, Hualuxe, Kimpton, and Voco are newer lifestyle brands experiencing strong demand. The company launched a midscale brand, Avid, in 2017 and closed on a 51% stake in Regent Hotels in 2018. It acquired Six Senses in 2019 and launched another midscale brand, Garner, in 2023. Managed and franchised represent 99% of total rooms. As of Dec. 31, 2023, the Americas represented 55% of total rooms, with Greater China accounting for 19% and Europe, Asia, the Middle East, and Africa making up 26%.

About NEUP Neuphoria Therapeutics Inc. Common Stock

Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.

Share on Social Networks: